Release Date: December, 2002
Paperback
|
From Book News, Inc.
This textbook outlines the basic science and clinical use of biotechnology-produced pharmaceuticals. The twenty chapters survey the chemical aspects of (glyco)proteins, the delivery and pharmacokinetic aspects of proteins, and the formulation of registered recombinant proteins. Originally published as Introductory textbook on pharmaceutical biotechnology, the second edition adds a chapter on economic considerations. Distributed by Taylor & Francis.Copyright © 2004 Book News, Inc., Portland, OR
Book Description
The field of pharmaceutical biotechnology is a rapidly evolving subject. A whole new arsenal of protein pharmaceuticals is being produced by recombinant techniques for a spectrum of serious diseases such as cancer, viral infections, cardiovascular and hereditary disorders. In addition, we are confronted with new technologies such as polymerase chain reactions, combinatorial chemistry and gene therapy.
Completely revised and updated, this introductory textbook provides extensive coverage of both the basic science and the applications of biotechnology-produced pharmaceuticals, with special emphasis on their clinical use.
Book Info
Introductory text provides extensive coverage on both the basic science and the applications of biotechnology-produced pharmaceuticals with special emphasis on their clinical use. Previous edition c1997. Softcover. Hardcover available.
About the Author
Daan J.A. Crommelin is at Utrecht University in The Netherlands. Robert D. Sindelar is at the University of Mississippi School of Pharmacy in the USA. Rating
|
|
